To include your compound in the COVID-19 Resource Center, submit it here.

CAT, AZN antibody deal

Cambridge Antibody (LSE:CAT; CATG) and AstraZeneca (LSE:AZN; AZN) partnered to discover and develop monoclonal antibodies to treat inflammatory and respiratory diseases. CAT is responsible for antibody discovery

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE